Table 2.
First year | Second year | Third year | Total | |
---|---|---|---|---|
Patients with additional nodal mets (after SLN 2+) | 35/81 (43%) | 21/42 (50%) | 20/52 (38%) | 76/175a (43%) |
Patients with additional nodal mets (after SLN 1+) | 6/36 (17%) | 6/41 (15%) | 3/20 (15%) | 15/97a (15%) |
a2 patients after 2+ and 48 after 1+ refused complete nodal dissection following data from Galimberti et al. (5).